ASTH
Astrana Health Inc
NASDAQ · Health Care
$21.10
-0.61 (-2.81%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.13B | 1.54B | 238.84M | 223.81M | 220.72M |
| Net Income | 45.11M | 29.42M | 34.39M | 27.08M | 34.10M |
| EPS | — | — | — | — | — |
| Profit Margin | 2.1% | 2.0% | 14.4% | 12.1% | 15.5% |
| Rev Growth | +38.0% | +38.0% | +23.8% | +6.3% | +23.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 200.79M | 200.79M | 123.37M | 106.35M | 104.79M |
| Total Equity | 328.35M | 328.35M | 624.01M | 647.23M | 610.21M |
| D/E Ratio | 0.61 | 0.61 | 0.20 | 0.16 | 0.17 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 128.47M | 88.43M | 38.94M | 43.50M | 42.89M |
| Free Cash Flow | — | — | 15.89M | 22.81M | 15.27M |